Oncology

Our Team

Our multidisciplinary team of physicians consists of urologists, medical oncologists, radiation oncologists, pathologists and radiologists with support from oncology nurses and social services staff.

About the Program

Our program is for patients seeking treatment for genitourinary cancers including cancer of the prostate, kidney, bladder, testes, adrenal glands, urethra and penis.

Patients may be newly diagnosed, seeking second opinions, facing recurrences of cancer or requiring the level of expertise provided by University Hospital's cancer specialists and our state-of-the-art diagnostic and therapeutic equipment.

We Offer

  • Consultation
  • Evaluation
  • Treatment
  • Prevention and education

Our Physicians

Our physicians have both academic and clinical appointments at Upstate Medical University and its teaching hospital, University Hospital. Many of them are also involved in research projects. Consequently, their level of knowledge and skill in their particular specialty is unlikely to be found in most other health care settings.

Gennady Bratslavsky, MD
Gennady Bratslavsky, MD
315 464-4473

Education & Fellowships

  • Fellowship: National Cancer Institute, NIH, Bethesda, MD, 2007, Urologic Oncology
  • Residency: Albany Medical Center Hospital, 2005, Urologic Surgery
  • MD: Albany Medical College, NY, 2000

Diseases/Specialties/Treatments

Urology; Urologic Oncology; Advanced Prostate Cancer; Bladder Cancer; Kidney Cancer; Prostate Cancer; more

Research Interests

  • Molecular imaging of prostate, kidney, and bladder cancer
  • Progression of prostate and kidney cancer
  • Biomarkers, circulating tumor cells (CTCs)

Education Interests

  • Resident and student mentoring in basic and clinical research

Clinical Interests

  • Outcome evaluations of minimally invasive robot-assisted and laparoscopic prostate and kidney surgery

Associations/Memberships

  • American Urological Association (AUA)
  • Society of Urologic Oncology
  • Onondaga County Medical Society

Rakesh Khanna, MD
Rakesh Khanna, MD
315 464-1500

Education & Fellowships

  • Fellowship: Cleveland Clinic, 2011, Minimally Invasive and Robotic Surgery Fellow
  • Fellowship: Toronto General Hospital, Toronto, Canada, 2009, Endourology Fellow
  • Residency: McGill University, Montreal, Quebec, 2008, Urology
  • Internship: McGill University, Montreal, Quebec, 2003

Diseases/Specialties/Treatments

Urology; Urologic Oncology; Adrenal Gland Cancer; Bladder Cancer; Kidney Cancer; Prostate Cancer; more

Oleg Shapiro, MD
Oleg Shapiro, MD
315 464-1500

Education & Fellowships

  • MD: SUNY Upstate Medical University
  • Residency: University Hospital, Upstate Medical University, Syracuse, NY
  • Certificate of Advanced Study: Fox Chase Cancer Center, Philadelphia, PA, 2008, Urologic Oncology

Diseases/Specialties/Treatments

Urology; Advanced Prostate Cancer; Bladder Cancer; Kidney Cancer; Nephrolithiasis (Kidney Stones); Prostate Cancer; more

Research Interests

  • Kidney and Bladder Cancers

Education Interests

  • Medical Student Clerkship Director

Clinical Interests

  • Urologic Cancers, Stone Disease

Associations/Memberships

  • American College of Surgeons (ACS), Fellow
  • American Urological Association (AUA)

Srinivas Vourganti, MD
Srinivas Vourganti, MD
315 464-1500

Education & Fellowships

  • Fellowship: National Cancer Institute, NIH, Bethesda, MD, 2013, Urologic Oncology, Robotic and Minimally Invasive Surgery, Prostate Imaging
  • Residency: Case Western Reserve University School of Medicine, 2010, Urologic Surgery
  • MD: Ohio State University College of Medicine, 2004, Urology

Diseases/Specialties/Treatments

Urology; Urologic Oncology; Adrenal Gland Cancer; Bladder Cancer; Kidney Cancer; Penile Cancer; more

Research Interests

  • Urologic Cancer (Prostate, Bladder, Kidney, Testis, Urethral, Adrenal Cancer), including Prostate MRI, Prostate Cancer Diagnostics, and Targeted Therapy

Education Interests

  • Education of Medical Students, Residents, and Graduate Students in Oncology

Clinical Interests

  • Minimally Invasive and Robotic Surgery for Urologic Cancer

Associations/Memberships

  • American Urological Association (AUA)
  • Society of Urologic Oncology
  • American Society of Clinical Oncology - ASCO

Program Benefits

The multidisciplinary approach to the management of genitourinary cancer has significant benefits for our patients. These include a clear presentation of treatment options for the patient to consider, without the need to meet individually with several different specialists; expedited medical imaging and laboratory results; and generally a shorter time between diagnosis and the initiation of treatment.

The program provides patients with evaluations by a urologist, medical oncologist and radiation oncologist in a single visit. All medical records, x-rays and laboratory test results are reviewed and discussed by the physicians and treatment plans customized for each patient. Every treatment plan takes into consideration quality of life issues and how normal body functions may be maintained whenever possible. Referring physicians are welcome to attend the consultation.

Treatment Options

Treatment may involve surgery, radiation, chemotherapy or immunotherapy, or a combination of these therapies. Beyond its physical effects, genitourinary cancer often has a significant emotional and psychological impact on patients and their families. Part of the treatment plan may include referral to a psychiatrist, psychologist or social worker or a recommendation that patients and family members participate in a cancer support group.

Following the evaluation by our team of specialists, treatment recommendations are sent to the referring physician. Patients may be treated at University Hospital or may be referred to their primary care physician for management.

Access to New Therapies

Upstate Medical University is one of only 125 medical universities in the nation. Our physicians and researchers are involved in numerous cancer research projects in association with other major institutions and cancer organizations. When appropriate, patients are invited to participate in clinical trials designed to evaluate the newest and most promising treatments.

Prevention and Education

An important component of our cancer program involves prevention and education to reduce the incidence of cancer. As recognized experts in the area of genitourinary cancers, our physicians are frequently invited to present to both professional organizations and to the public.